top of page

COVID-19 Vaccination Clinics Open to Clinically Extremely Vulnerable 16 years and older

Central Health is now inviting those individuals identified as clinically extremely vulnerable to book appointments for COVID-19 vaccination. Please see below a list of clinically extremely vulnerable groups or check out the following link:

All Clinically Extremely Vulnerable Patients should complete the following checklist prior to booking an appointment:

  • Based on the information provided identify the best time to book their vaccine appointment.

  • Monitor how they are feeling leading up to their vaccination appointment. Is anything new or getting worse compared to how they usually feel?

  • Make sure they are feeling their usual self on the day of their vaccine appointment.

  • Talk to their doctor if they have any questions

To book an appointment at one of the available clinics:

While this is an open call for anyone who is clinically extremely vulnerable, Central Health will be reaching out directly to specific groups such as Cancer Care and Dialysis to assist in planning vaccination.

If anyone is experiencing difficultly booking their appointment contact 1-833-961-3749 between 8 a.m. and 8 p.m. Individuals will know when the clinics are full when there are no longer any available appointment slots available in the online system. If an appointment is no longer available in the community/clinic of choice, more clinics will be available in the future. However, people should continue to check the Central Health website as we are continuing to add clinics weekly.

In keeping with public health guidance to reduce the number of contacts wherever possible, patients are asked to carefully consider the necessity of an attendee when visiting these areas. Although support persons are encouraged to attend when needed, patients who can safely manage their interaction for out-patient care without assistance/support should attend the vaccine clinic unaccompanied.

The public is reminded that they should not schedule an appointment for a vaccine if they are experiencing symptoms of COVID-19. Instead, complete a COVID-19 Assessment and referral by clicking here.

For more information on COVID-19 vaccines, please visit Health Canada or the Government of Newfoundland and Labrador’s vaccine information sheet found at For up-to-date information on the COVID-19 pandemic, please visit

Clinically Extremely Vulnerable include:

  • Solid organ transplant recipients.

  • People with specific cancers:

    • People on active/recently completed cytotoxic chemotherapy (within last12 months) or having other targeted cancer treatments that can affect the immune system, such as protein kinase inhibitors, PARP inhibitors or CDK4/6 inhibitors;

    • People with cancers of the blood or bone marrow such as leukemia, lymphoma and multiple myeloma at any stage of treatment;

    • People with lung cancers;

    • Patients on treatment with monoclonal antibodies or immune therapy;

    • People who have had bone marrow or stem cell transplants in the last six months or who are still taking immunosuppression drugs; and

    • Patients on treatment with different anti-cancer hormonal medications (e.g. breast and prostate cancers)

  • Respiratory patients:

    • All patients on chronic oxygen therapy (regardless of disease);

    • All patients greater than 16 years of age with cystic fibrosis;

    • All patients with interstitial lung disease (e.g. idiopathic pulmonary fibrosis, CTD-ILD, etc.);

    • Patients with pulmonary hypertension (PH) requiring PH-specific therapy;

    • Any asthma or chronic obstructive pulmonary disease (COPD) patient with a severe exacerbation in the previous year (resulting in emergency room visit or admission); and

    • Any patient with severe lung disease based on PFT (FVC or FEV1 or TLC <50 per cent).

  • People with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell disease);

  • People on immunosuppression therapies enough to significantly increase risk of infection (biologic modifiers, steroid use ≥20mg/day for ≥14 days, AZT, cyclophosphamide);

  • People who have had their spleen removed;

  • Those over 16 years of age with significant intellectual or developmental disabilities;

  • Adults on dialysis or stage 5 kidney disease;

  • Women who are pregnant with significant heart disease, congenital or acquired; and

  • People with significant neuromuscular conditions requiring respiratory support.


Media contact:

Gayle St. Croix

Director, Communications



bottom of page